Oxford Asset Management »

Humacyte shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $63k 20k 3.11

More positions owned by Oxford Asset Management

Stellantis SHS (STLA)
Draftkings Com Cl A (DKNG)
Cannae Holdings (CNNE)
Geopark Usd Shs (GPRK)
Philip Morris International (PM)
Adobe Systems Incorporated (ADBE)
Overseas Shipholding Group I Cl A New (OSG)
Zoetis Cl A (ZTS)
Snap Cl A (SNAP)
Alphabet Cap Stk Cl A (GOOGL)
R1 RCM (RCM)
Medical Properties Trust Call Option (MPW)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Archer Daniels Midland Company (ADM)
Cooper Cos (COO)

View all positions for Oxford Asset Management

Top funds holding Humacyte

BlackRock
Vanguard Group
AIGH Capital Management
Sio Capital Management
Geode Capital Management
Monashee Investment Management
Prescott General Partners
Northern Trust
Charles Schwab Investment Management
LPL Financial
Citadel Advisors
Private Advisor
Capstone Investment Advisors
Millennium Management
Lion Point Capital

View all funds holding Humacyte